MERS-CoV Real Time PCR Kit: RUO Status Shapes Procurement Checks

MERS-CoV Real Time PCR Kit

Laboratories evaluating MERS-CoV testing reagents must match kit format, sample types, and throughput to existing extraction and PCR platforms. This kit is listed for nasopharyngeal and oropharyngeal swabs, with 25-test and 50-test package options.

Its stated LoD is 5 copies/reaction and assay runtime is 79 minutes, excluding extraction. Those figures describe the amplification step and do not account for sample preparation or result review time.

Storage is -20±5°C with 12-month shelf life. That places demands on freezer capacity, shipment validation, and inventory rotation, especially where MERS testing demand is low or seasonal.

The product page identifies the regulatory status as RUO. RUO labeling generally does not support clinical diagnostic claims, even when the text refers to diagnostic testing related to MERS-CoV. Buyers should verify intended use against local rules.

Procurement should confirm kit configuration, extraction compatibility, instrument channel requirements, internal controls, and documentation provided with each lot. The input lists package sizes and catalog numbers but not instrument compatibility.

For MERS-CoV, low case volumes can make reagent shelf life and lot management decisive. A kit’s technical fit matters, but documentation, storage, and regulatory status often determine whether it can be deployed.

Why it matters:
Before ordering, confirm whether RUO status is acceptable for the intended setting and whether extraction, PCR instrumentation, and cold-chain logistics are validated locally.

View Product →